Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- TA337081 - Provider product page
- Provider
- OriGene
- Product name
- Mouse Monoclonal Bax inhibitor 1 Antibody (20F565)
- Antibody type
- Monoclonal
- Description
- Mouse Monoclonal Bax inhibitor 1 Antibody (20F565)
- Host
- Mouse
- Conjugate
- Unconjugated
- Epitope
- TMBIM6
- Isotype
- IgG
- Antibody clone number
- 20F565
- Vial size
- 100 µg
- Concentration
- 0.5 mg/ml
No comments: Submit comment
Supportive validation
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Western Blot: Bax inhibitor 1 Antibody (20F565) [TA337081] - analysis of Bi-1 with this antibody. Lane 1: in vitro translated human Bi-1 protein. Lanes 2 and 3: IP/WB of Bi-1 protein enriched in the transgenic mouse brain (Lane 2) or wildtype brain (Lane
- Validation comment
- WB
Supportive validation
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: Bax inhibitor 1 Antibody (20F565) [TA337081] - analysis of Bi-1 using Bi-1 antibody at 5 ug/ml: A) overview of stained human and mouse TMA, B-C) immunoreactivity in human archicortex (positive neurons of hippocampal gyrus) a
- Validation comment
- IHC
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: Bax inhibitor 1 Antibody (20F565) [TA337081] - Formalin-fixed, paraffin-embedded human brain stained with Bi-1 antibody at 0.5 ug/ml.Staining of formalin-fixed tissues is enhanced by boiling tissue sections in 10 mM sodium c
- Validation comment
- IHC
- Submitted by
- OriGene (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: Bax inhibitor 1 Antibody (20F565) [TA337081] - IHC analysis of formalin-fixed paraffin-embedded tissue section of human liver cancer using 5 ug/ml concentration of Bax inhibitor 1 antibody (clone 20F565). Cytoplasmic immuno-
- Validation comment
- IHC